VERAMORPH
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers. The company was founded in 2017 and is headquartered in Mansfield, Massachusetts.
VERAMORPH
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-01-01
Address:
Mansfield, Massachusetts, United States
Country:
United States
Website Url:
http://www.veramorph.com
Total Employee:
1+
Status:
Active
Contact:
617-657-9914
Total Funding:
225 K USD
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Disc Medicine
Disc Medicine is a hematology company
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
PerioTrap Pharmaceuticals GmbH
PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Veramorph
Official Site Inspections
http://www.veramorph.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Veramorph"
Home | VeraMorph
VeraMorph has developed a proprietary oral drug delivery platform that we are leveraging to help companies improve and accelerate clinical translation of poorly soluble lead compounds and …See details»
About Us - VeraMorph
VeraMorph is a pre-clinical strategic pharmaceutical company driven by the mission of prolonging and improving patient lives by maximizing the therapeutic potential of any and all therapeutic …See details»
Portfolio | VeraMorph
Considering about 40% of approved drug products are poorly soluble, and a majority are incompatible with current technologies, VeraMorph is developing novel, clinically-differentiated …See details»
VeraMorph Company Profile 2024: Valuation, Funding & Investors
Developer of an oral drug delivery technology designed to provide contract manufacturing and formulation services using proprietary oral hydrogel tablets.See details»
Veramorph - Crunchbase Company Profile & Funding
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers. The company was founded in 2017 and is headquartered in Mansfield, …See details»
VeraMorph - LinkedIn
VeraMorph is a specialty pharmaceutical start-up developing a polymer-based oral dosage technology to improve the therapeutic index of poorly soluble small molecules, which account for roughly...See details»
Veramorph LLC — National Science Foundation
Dive into the research topics where Veramorph LLC is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.See details»
VeraMorph - Company Profile - Tracxn
Dec 21, 2023 · VeraMorph - Developer of polymer-based oral drug delivery platform. Raised a total funding of $222K over 1 round. Founded by Doug Godfrin in the year 2017. VeraMorph …See details»
Veramorph - Crunchbase
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.See details»
NSF Award Search: Award # 2231141 - NSF - National Science …
As a risk-averse industry, pharmaceutical innovation prioritizes the active ingredients that address disease. However, this project could demonstrate that innovative inactive ingredients can …See details»
Veramorph LLC - VentureRadar
VeraMorph is expanding oral delivery of poorly soluble drugs with a proprietary oral solid dosage technology. Disintegrating Pre-formed Oral Dosages (DPODs) simplify drug product design …See details»
MCET Technologies & Veramorph win a DuPont ... - The …
Veramorph is a startup that leverages an advanced proprietary hydrogel based oral drug delivery platform to help pharmaceutical companies improve the performance of their products and …See details»
Technology - VeraMorph
VeraMorph's platform technology, referred to as DPODs (Dissociated Polymeric Oral Dosages), utilizes a unique mechanism of action whereby an initially chemically cross-linked polymer …See details»
Veramorph lands spot in Delaware accelerator - Drug Delivery …
Jul 30, 2019 · Veramorph Materials landed a spot in a Delaware business accelerator backed by DuPont to develop its hydrogel-based oral drug delivery platform. Veramorph and MCET …See details»
Veramorph - Funding, Financials, Valuation & Investors - Crunchbase
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.See details»
VeraMorph - Products, Competitors, Financials, Employees, …
VeraMorph operates as a specialty pharmaceutical company focused on improving the therapeutic potential of poorly soluble small molecules within the pharmaceutical industry. Use …See details»
Contact Us - VeraMorph
Contact Us. Thank you for your interest in VeraMorph. To contact us please reach us via:See details»
Veramorph LLC Company Profile | Mansfield, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Veramorph LLC of Mansfield, MA. Get the latest business insights from Dun & Bradstreet.See details»
Veramorph - Contacts, Employees, Board Members, Advisors
Veramorph has 1 current employee profile, Founder and CEODoug Godfrin. VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.See details»
Fulvestrant - VeraMorph - AdisInsight - Springer
An oral formulation of fulvestrant, an estrogen receptor antagonist, is being developed by VeraMorph for the treatment of breast cancer. VeraMorph is leveraging.See details»